查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
核酸樣品製備市場 - 2018-2028年全球行業規模、佔有率、趨勢、競爭、機會及預測（按產品、技術、治療領域、應用、終端用戶、地區和競爭分類
市場調查報告書
商品編碼
1309864

核酸樣品製備市場 - 2018-2028年全球行業規模、佔有率、趨勢、競爭、機會及預測（按產品、技術、治療領域、應用、終端用戶、地區和競爭分類

Nucleic Acid Sample Preparation Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Technology, By Therapeutic Area, By Application, By End Users,By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在2024-2028 年的預測期內，核酸樣品製備市場的複合年成長率預計將達到驚人的水準。這主要歸因於核酸分子在各種治療領域的應用日益廣泛等因素。

生命科學領域的研發不斷成長

政府、學術界和機構等為擴大生命科學研究而增加的投資預計將推動核酸樣品製備市場的需求。例如，2022 年2 月，Brightlamp 公司和普渡大學附屬Amplified Sciences LLC 公司分別從普渡大學鑄造投資基金獲得了約25 萬美元的研發資助，以推動生命科學的發展。 Amplifies Sciences 正在研究用於癌症和其他疾病預診斷的先進技術。同樣，Brightlamp 也是一家利用機器學習和電腦視覺來加強和改善醫療保健的公司。

核酸在治療領域的應用不斷成長

隨著對及時診斷疾病的需求不斷成長，以及在一些患者治療過程中對診斷資訊的需求，開發出了不同的分子程序，從而增加了核酸樣本提取以跟進診斷程序，預計這將為核酸樣本製備市場帶來豐厚的需求。此外，癌症等慢性疾病的發病率不斷上升，增加了分子水準診斷的需求，因此核酸樣本提取和製備需求的增加推動了預測期內的市場成長。此外，樣本製備也是精準醫療中的一項重要應用，因為它能確保安全水準並成功使用客製化療法。

對核酸提取系統的需求不斷成長

核酸分離/提取是分子診斷或任何分子實驗室研究中最基本的步驟，隨著用於提取樣本的各種設備和方法的出現，這一領域也在不斷擴大。自動核酸提取系統的出現促進了核酸樣品製備市場的成長。此外，自動化程度的提高還能以最小的誤差率同時運行多個樣本，還能從血清、組織、細胞培養等不同樣本中提取核酸，因此有望加速核酸樣本製備市場的發展。例如，2020 年2 月，市場參與者Covaris 公司推出了兩款新型試劑盒，用於利用喉嚨或鼻拭子採集裝置提取病毒RNA，其中包括truXTRAC-PCR 直接病毒RNA 提取試劑盒和truXTRAC 病毒RNA 提取試劑盒。

下一代測序需求成長（下游應用）

疾病中對下一代測序（NGS）需求的增加推動了核酸樣品製備市場的需求。基因或靶向序列攜帶著感興趣的基因或疾病載體，因此可被識別並用於疾病診斷。此外，靶向測序允許研究人員針對特定的興趣基因、編碼區甚至染色體片段進行測序，使其成為一種有用的測序技術，以收集準確、快速和精確的數據。在預測期內，用於測序程序的試劑盒和開發試劑的可用性將支持市場的成長並促進核酸樣品製備市場的發展。

最新動態

主要市場參與者正在推出新產品並擴大其產品組合。例如，2020 年2 月，Miroculus 公司推出了新型系統Miro Canvas，該系統可將複雜的方案（如巢代測序文庫製備）自動化、簡單化和微型化。

可客製化

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。本報告提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 市場覆蓋範圍
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目標
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4 章: 臨床試驗分析

  • 正在進行的臨床試驗
  • 已完成的臨床試驗
  • 終止的臨床試驗
  • 按開發階段分類的管線細分
  • 按狀態分類的管線
  • 按研究類型分類的管線細分
  • 按地區分類
  • 臨床試驗熱圖

第5 章：客戶之聲

第6章：核酸樣品製備市場展望

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按產品（耗材、系統和附件及組件）
    • 按技術（旋轉柱技術、磁珠技術及其他）
    • 按治療領域（腫瘤學、傳染病、人類遺傳學/群體遺傳學及其他）
    • 按應用（基因組學、蛋白質組學及其他）
    • 按最終用戶（學術和研究機構、製藥和生物技術公司、臨床和診斷實驗室及其他）
    • 按公司（2022 年）
    • 按地區
  • 產品市場圖

第7 章：亞太地區核酸樣品製備市場展望

  • 市場規模與預測
    • 按價值
  • 市場佔有率及預測
    • 產品
    • 技術
    • 治療領域
    • 應用領域
    • 終端用戶
    • 按國家
  • 亞太地區：國家分析
    • 中國.
    • 印度.
    • 印度.
    • 日本
    • 澳大利亞

第8 章: 歐洲核酸樣品製備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品
    • 技術
    • 治療領域
    • 應用領域
    • 終端用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9 章：北美腐殖基生物刺激劑市場前景。

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品
    • 技術
    • 治療領域
    • 應用領域
    • 終端用戶
    • 按國家
  • 北美洲：國家分析
    • 美國核酸樣品製備市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 產品
        • 技術
        • 治療領域
        • 應用領域
        • 終端用戶
    • 墨西哥核酸樣品製備市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 產品
        • 技術
        • 治療領域
        • 應用領域
        • 終端用戶
    • 加拿大核酸樣品製備市場前景
      • 市場規模與預測
        • 按價值
      • 市場佔有率與預測
        • 產品
        • 技術
        • 治療領域
        • 應用領域
        • 最終用戶

第10 章: 南美核酸樣品製備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品
    • 技術
    • 治療領域
    • 應用領域
    • 終端用戶
    • 按國家分類
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11 章：中東和非洲核酸樣品製備市場展望

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 產品
    • 技術
    • 治療領域
    • 應用領域
    • 終端用戶
    • 按國家
  • 中東和非洲：國家分析
    • 南非核酸樣品製備
    • 沙烏地阿拉伯核酸樣品製備
    • 阿拉伯聯合大公國核酸樣品製備
    • 科威特核酸樣品製備

第12 章：市場動態

  • 驅動因素
  • 挑戰

第13 章：市場趨勢與發展

  • 近期動態
  • 合併與收購
  • 產品開發

第14章：競爭格局

  • 業務概述
  • 公司概況
  • 產品與服務
  • 財務狀況（上市公司）
  • 近期發展
  • SWOT 分析
    • BGI Group (MGI Tech Co., Ltd.)
    • F. Hoffmann-La Roche Ltd
    • Danaher. (Beckman Coulter, Inc.)
    • Eppendorf SE
    • Bioneer Corporation
    • Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • Merck KGaA
    • Norgen Biotek Corp
    • Aurora Biomed Inc.
    • Agilent Technologies, Inc

第15 章：戰略建議

簡介目錄
Product Code: 14942

Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.

Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.

Growing Research & Development in Life Sciences

Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.

Growing Usage of Nucleic Acid in Therapeutic Areas

With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.

Growing Demand for Nucleic Acid Extraction Systems

Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.

Growing demand for Next generation Sequencing (Downstream applications)

The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.

Recent Developments

Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. introduced its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.

Market Segmentation

The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users, and region. Based on product, the market is further segmented into consumables, systems, and accessories & components. Based on technology, the market is further segmented into spin-column-based technology, magnetic-bead-based technology, and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics, and others. Based on end users, the market is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher. (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc., are some of the major players operating in the global nucleic acid sample preparation Market.

Report Scope

In this report, Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Nucleic Acid Sample Preparation, By Product:

  • Consumables
  • Systems
  • Accessories & Components

Nucleic Acid Sample Preparation, By Technology:

  • Spin-Column-Based Technology
  • Magnetic-Bead Based Technology
  • Others

Nucleic Acid Sample Preparation, By Therapeutic Area:

  • Oncology
  • Infectious Disease
  • Human Genetics/Population Genetics
  • Others

Nucleic Acid Sample Preparation, By Application:

  • Genomics
  • Proteomics
  • Others

Nucleic Acid Sample Preparation, By End Users:

  • Academic and Research Institutions
  • Pharmaceutical
  • Biotechnology Companies
  • Clinical and Diagnostic Laboratories
  • Other

Nucleic Acid Sample Preparation, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Nucleic Acid Sample Preparation market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Clinical Trial Analysis

  • 4.1. Ongoing Clinical Trials
  • 4.2. Completed Clinical Trials
  • 4.3. Terminated Clinical Trials
  • 4.4. Breakdown of Pipeline, By Development Phase
  • 4.5. Breakdown of Pipeline, By Status
  • 4.6. Breakdown of Pipeline, By Study Type
  • 4.7. Breakdown of Pipeline, By Region
  • 4.8. Clinical Trials Heat Map

5. Voice of Customer

6. Nucleic Acid Sample Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Systems and Accessories & Components)
    • 6.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others)
    • 6.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
    • 6.2.4. By Application (Genomics, Proteomics and Others)
    • 6.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories and Other)
    • 6.2.6. By Company (2022)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Product
    • 7.2.2. Technology
    • 7.2.3. Therapeutic Area
    • 7.2.4. Application
    • 7.2.5. End Users
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Product
        • 7.3.1.2.2. Technology
        • 7.3.1.2.3. Therapeutic Area
        • 7.3.1.2.4. Application
        • 7.3.1.2.5. End Users
    • 7.3.2. India Nucleic Acid Sample Preparation Market Outlook.
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Product
        • 7.3.2.2.2. Technology
        • 7.3.2.2.3. Therapeutic Area
        • 7.3.2.2.4. Application
        • 7.3.2.2.5. End Users
    • 7.3.3. South Korea Nucleic Acid Sample Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Product
        • 7.3.3.2.2. Technology
        • 7.3.3.2.3. Therapeutic Area
        • 7.3.3.2.4. Application
        • 7.3.3.2.5. End Users
    • 7.3.4. Japan Nucleic Acid Sample Preparation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Product
        • 7.3.4.2.2. Technology
        • 7.3.4.2.3. Therapeutic Area
        • 7.3.4.2.4. Application
        • 7.3.4.2.5. End Users
    • 7.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Product
        • 7.3.5.2.2. Technology
        • 7.3.5.2.3. Therapeutic Area
        • 7.3.5.2.4. Application
        • 7.3.5.2.5. End Users

8. Europe Nucleic Acid Sample Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Product
    • 8.2.2. Technology
    • 8.2.3. Therapeutic Area
    • 8.2.4. Application
    • 8.2.5. End Users
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Nucleic Acid Sample Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Product
        • 8.3.1.2.2. Technology
        • 8.3.1.2.3. Therapeutic Area
        • 8.3.1.2.4. Application
        • 8.3.1.2.5. End Users
    • 8.3.2. Germany Nucleic Acid Sample Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Product
        • 8.3.2.2.2. Technology
        • 8.3.2.2.3. Therapeutic Area
        • 8.3.2.2.4. Application
        • 8.3.2.2.5. End Users
    • 8.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Product
        • 8.3.3.2.2. Technology
        • 8.3.3.2.3. Therapeutic Area
        • 8.3.3.2.4. Application
        • 8.3.3.2.5. End Users
    • 8.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. Product
        • 8.3.4.2.2. Technology
        • 8.3.4.2.3. Therapeutic Area
        • 8.3.4.2.4. Application
        • 8.3.4.2.5. End Users
    • 8.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. Product
        • 8.3.5.2.2. Technology
        • 8.3.5.2.3. Therapeutic Area
        • 8.3.5.2.4. Application
        • 8.3.5.2.5. End Users

9. North America Humic-based bio stimulants Market Outlook.

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Product
    • 9.2.2. Technology
    • 9.2.3. Therapeutic Area
    • 9.2.4. Application
    • 9.2.5. End Users
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Nucleic Acid Sample Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Product
        • 9.3.1.2.2. Technology
        • 9.3.1.2.3. Therapeutic Area
        • 9.3.1.2.4. Application
        • 9.3.1.2.5. End Users
    • 9.3.2. Mexico Nucleic Acid Sample Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Product
        • 9.3.2.2.2. Technology
        • 9.3.2.2.3. Therapeutic Area
        • 9.3.2.2.4. Application
        • 9.3.2.2.5. End Users
    • 9.3.3. Canada Nucleic Acid Sample Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Product
        • 9.3.3.2.2. Technology
        • 9.3.3.2.3. Therapeutic Area
        • 9.3.3.2.4. Application
        • 9.3.3.2.5. End Users

10. South America Nucleic Acid Sample Preparation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Product
    • 10.2.2. Technology
    • 10.2.3. Therapeutic Area
    • 10.2.4. Application
    • 10.2.5. End Users
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Product
        • 10.3.1.2.2. Technology
        • 10.3.1.2.3. Therapeutic Area
        • 10.3.1.2.4. Application
        • 10.3.1.2.5. End Users
    • 10.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Product
        • 10.3.2.2.2. Technology
        • 10.3.2.2.3. Therapeutic Area
        • 10.3.2.2.4. Application
        • 10.3.2.2.5. End Users
    • 10.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Product
        • 10.3.3.2.2. Technology
        • 10.3.3.2.3. Therapeutic Area
        • 10.3.3.2.4. Application
        • 10.3.3.2.5. End Users

11. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. Product
    • 11.2.2. Technology
    • 11.2.3. Therapeutic Area
    • 11.2.4. Application
    • 11.2.5. End Users
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. Product
        • 11.3.1.2.2. Technology
        • 11.3.1.2.3. Therapeutic Area
        • 11.3.1.2.4. Application
        • 11.3.1.2.5. End Users
    • 11.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. Product
        • 11.3.2.2.2. Technology
        • 11.3.2.2.3. Therapeutic Area
        • 11.3.2.2.4. Application
        • 11.3.2.2.5. End Users
    • 11.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. Product
        • 11.3.3.2.2. Technology
        • 11.3.3.2.3. Therapeutic Area
        • 11.3.3.2.4. Application
        • 11.3.3.2.5. End Users
    • 11.3.4. Kuwait Nucleic Acid Sample Preparation Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. Product
        • 11.3.4.2.2. Technology
        • 11.3.4.2.3. Therapeutic Area
        • 11.3.4.2.4. Application
        • 11.3.4.2.5. End Users

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (In case of listed companies)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. BGI Group (MGI Tech Co., Ltd.)
    • 14.6.2. F. Hoffmann-La Roche Ltd
    • 14.6.3. Danaher. (Beckman Coulter, Inc.)
    • 14.6.4. Eppendorf SE
    • 14.6.5. Bioneer Corporation
    • 14.6.6. Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 14.6.7. Merck KGaA
    • 14.6.8. Norgen Biotek Corp
    • 14.6.9. Aurora Biomed Inc.
    • 14.6.10. Agilent Technologies, Inc

15. Strategic Recommendations